DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on December 28, 2005; DOI: 10.1124/dmd.105.006197


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.006197v1
34/3/405    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anapolsky, A.
Right arrow Articles by Piquette-Miller, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anapolsky, A.
Right arrow Articles by Piquette-Miller, M.


Received for publication June 23, 2005.
Revised December 12, 2005.
Accepted for publication December 14, 2005.

The role of PXR in 2-AAF-mediated induction of drug transport and metabolizing enzymes in mice

Alexander Anapolsky 1, Shirley Teng 1, Santosh Dixit 2, Micheline Piquette-Miller 1*

1 University of Toronto 2 Vanderbilt University School of Medicine

* Address correspondence to: E-mail: m.piquette.miller{at}utoronto.ca

Abstract

Activation of the Pregnane X receptor (PXR) mediates the induction of several drug transporters and metabolizing enzymes. In vitro studies have reported that several of these genes are induced after exposure to the hepatocarcinogen, 2-acetylaminofluorene (2-AAF). Thus, we hypothesized that PXR may play a role in the in vivo induction of gene expression by 2-AAF. We examined the expression of the drug metabolizing enzymes CYP1A2 and CYP3A11 and the drug transporters BCRP, MRP2 and OATP2. Wild-type (PXR+/+) and PXR-null (PXR-/-) C57BL/6 mice were injected daily for 7 days with 150 or 300 mg/kg of 2-AAF suspended in corn oil (i.p.), while control group received corn oil vehicle. Levels of mRNA isolated from liver were measured by RT-PCR and normalized to {beta}-actin. Treatment of PXR+/+ mice resulted in a dose-dependent 2- to 4-fold induction (p<0.001) of MRP2, OATP2, BCRP, CYP3A11 and CYP1A2, but no induction was observed in PXR-/- mice. Induction of PXR mRNA was observed in the 2-AAF-treated PXR+/+ mice. Furthermore, a dose-dependent increase in CYP3A4 promoter construct activity was observed in HepG2 cells co-transfected with human or rat PXR, indicating that 2-AAF does indeed activate PXR. These results suggest that murine PXR is responsible for 2-AAF-mediated induction of drug efflux transporters and biotransformation enzymes in the liver. Moreover, novel findings demonstrate that PXR plays a role in regulation of the drug efflux transporter, BCRP, in mice.


Key words: ABC transporters, chemical carcinogenesis, CYP induction, cytochrome P450 regulation, hepatotoxicity, PXR, transporters


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
V. S. Narang, C. Fraga, N. Kumar, J. Shen, S. Throm, C. F. Stewart, and C. M. Waters
Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C440 - C450.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. Naspinski, X. Gu, G.-D. Zhou, S. U. Mertens-Talcott, K. C. Donnelly, and Y. Tian
Pregnane X Receptor Protects HepG2 Cells from BaP-Induced DNA Damage
Toxicol. Sci., July 1, 2008; 104(1): 67 - 73.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Chen, Y. Tang, M.-T. Wang, S. Zeng, and D. Nie
Human Pregnane X Receptor and Resistance to Chemotherapy in Prostate Cancer
Cancer Res., November 1, 2007; 67(21): 10361 - 10367.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
H. K. Choi, J. W. Yang, S. H. Roh, C. Y. Han, and K. W. Kang
Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells
Endocr. Relat. Cancer, June 1, 2007; 14(2): 293 - 303.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Fradette, J. Batonga, S. Teng, M. Piquette-Miller, and P. du Souich
Animal Models of Acute Moderate Hypoxia Are Associated with a Down-Regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and Up-Regulation of CYP3A6 and P-glycoprotein in Liver
Drug Metab. Dispos., May 1, 2007; 35(5): 765 - 771.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. Jigorel, M. Le Vee, C. Boursier-Neyret, Y. Parmentier, and O. Fardel
Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes
Drug Metab. Dispos., October 1, 2006; 34(10): 1756 - 1763.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.